Autologous genetically modified AFPᶜ³³²T cells clinical trials

AFPᶜ³³²T in Advanced HCC

This study looks at a new treatment for advanced liver cancer or other AFP-expressing tumours. It uses a patient's own immune cells, called T-cells, which are specially trained to find and destroy cancer cells.